News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
07
2025
-
02
United in purpose, winning the battle for 2025! Linuo Pharmaceutical held the 2025 target contract oath ceremony!
Classification：
News
行业新闻
Corporate News
123rd of the month,Linuo Pharmaceutical held a grand signing ceremony for the 2025 marketing center target commitment, with the company's management team participating in full. Marketing elites from all over the country gathered together to prepare for a strong start in the first quarter and to achieve the 2025 targets.
On the eve of the conference, to ensure that the marketing team meets the challenges of the new year with a more professional attitude, the company carefully organized multiple training activities covering financial management, product knowledge, market access strategies, and business process optimization, aiming to comprehensively enhance the professional quality and market adaptability of the marketing personnel. Through training, the marketing team not only deepened their understanding of the company's products but also mastered more practical market strategies and tools, laying a solid foundation for the upcoming work.
During the solemn and enthusiastic signing ceremony, marketing elites from various regions took the stage to sign the 2025 marketing target responsibility agreements with the company and showcased their teams. Each signed responsibility agreement represents a solemn commitment and responsibility, and embodies the marketing team's confidence and determination for the future.
In the subsequent reporting and communication session, the marketing leaders from various regions analyzed the current market situation and competitive landscape in detail, based on the market characteristics and actual conditions of their respective regions, and proposed practical marketing strategies and action plans for the 2025 task objectives. The reports were substantial and clear, fully demonstrating the professional quality and teamwork spirit of Linuo Pharmaceutical's marketing team. Various functional departments also expressed their determination and commitment to fully support marketing and empower the front line.
To recognize the advanced examples that emerged in 2024 and to encourage the marketing team to face the challenges of 2025 with a more positive attitude, the company held a grand commendation ceremony for the marketing team.Multiple awards were established, including "Rising Star," "Sales Star," "Best Sales Pioneer," "Overcoming Difficulties Award," and "Outstanding Manager." To the cheerful music, the award winners took the stage one by one to receive their awards, their faces beaming with pride and joy, inspiring more colleagues to strive to emulate them.
The convening of this conference injected strong motivation and confidence into Linuo Pharmaceutical's achievement of the 2025 tasks. "United in heart and effort, winning the battle for 2025!" This is not only a resounding slogan but also the common voice and action of Linuo Pharmaceutical's people. In 2025, all Linuo Pharmaceutical employees will work hand in hand, forge ahead with determination, and with a more vigorous fighting spirit, a more pragmatic style, and more innovative thinking, continuously create new situations and contribute all their strength to achieve a strong start in the first quarter and the 2025 goals!
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China